

产品介绍 评论(0)
物种
HumanAccession
Q8NHL6表达序列
Gly24-His458, with C-terminal 8*His
表达宿主
HEK293分子量
58-82kDa (Reducing)
纯度
>95% by SDS-PAGE
内毒素含量
<0.1EU/μg标记
Unconjugated标签
His Tag性状
Lyophilized Powder缓冲体系
PBS PH7.4
溶解方法
Reconstitute at 0.1-1 mg/mL according to the size in ultrapure water after rapid centrifugation.
储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
Leukocyte immunoglobulin (Ig)-like receptor B1 (LILRB1) is a member of leukocyte Ig-like receptors (LILRs), also known as CD85j, ILT2, LIR1, and MIR7, contains four extracellular immunoglobulin domains, and four intracellular ITIMs. It is expressed on monocytes, macrophages, DCs, eosinophils and basophils, mB cells, T cells, and natural killer (NK) cells, as well as on in vitro cultured cord blood-derived progenitor mast cells and osteoclasts. LILRB1 and HLA-I molecule interactions are dependent on the non-polymorphic α3 domain of the heavy chain and β2 microglobulin. LILRB1 additionally interacts with the UL18 molecules from human cytomegalovirus (HCMV), which is an HLA-I homolog, RIFIN molecules from Plasmodium falciparum, Dengue virus through an unidentified ligand, and the damage associated molecular pattern proteins S100A8 and S100A9. Recent studies suggest that LILRB1 on tumor cells stimulates immune responses in certain situations.
电泳
- 2μg (R: reducing condition, N: non-reducing condition).
ELISA
Immobilized LILRB1/CD85j/ILT2 His Tag Protein, Human(Cat.No. UA010090) at 2 μg/mL (100 μL/well) can bind Mouse Anti-Human CD85j Antibody (S-3041)(Cat.No.S0B5639), the EC50 is 1.4-3.1ng/mL







评论(0)